Time To Comment On ‘Bold New Regulatory Regime’ For UK
Executive Summary
Unconstrained by having to compromise with other countries’ regulatory approaches, the UK is now seeking views on its proposal for a pioneering and “bold new regulatory regime” for medtech products.
You may also be interested in...
UK’s Ambitious Plan For Medtech Regulation Merits Attention
The MHRA’s efforts to give the UK a nimble, responsive, innovation-facing medtech regulatory system earnt high marks from Bristows’ Alex Denoon, who assessed the opportunity at hand during the MedTech Summit.
No Quick Fix When It Comes To EU Medtech Notified Body Designations
Latest information from the European Commission suggest that future notified bodies designated under the MDR, and even the IVDR, may not be in a position to issue certificates until March 2023.
EU Reference Laboratory Candidates Invited To Apply In Context of IVDR Regulation
The highest risk IVDs are due to receive an extra layer of regulatory scrutiny in the EU. But it is taking a long time to set up the structures needed.